Home
Enveda Therapeutics, Inc.

Enveda Therapeutics, Inc. Market Share Analysis for June 2026

Computers Electronics and Technology > Graphics Multimedia and Web Design

Domainenvedabio.com

Year Founded2019

Employees201 - 500

Annual Revenue$25M - $50M

Enveda Therapeutics, Inc.

Enveda Therapeutics, Inc. (including company regionals)

envedabio.com

See more website traffic and engagement information

Enveda Therapeutics, Inc. Revenue up to June 2026 is 25M - 50M

revenue generated by Enveda Therapeutics, Inc. top domains

Enveda Therapeutics, Inc. top domains revenue over 3 years

Revenue for Enveda Therapeutics, Inc. top domains

envedabio.com25M - 50M

See more with Sales Intelligence

Total visits to Enveda Therapeutics, Inc.'s top domains

Understand Enveda Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

envedabio.com283

See more with Sales Intelligence

Avg. visit duration in Enveda Therapeutics, Inc.'s top domains

Analyze Enveda Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Enveda Therapeutics, Inc.'s top domains

See how Enveda Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

envedabio.com1.00

See more with Sales Intelligence

Enveda Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Enveda Therapeutics, Inc.

These are the website technologies, by industry, used by Enveda Therapeutics, Inc. top domains

Content Management System (4)

WordPress

Social (3)

Facebook Social Plugins

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

More Technologies

9

See all

News & Signals from Enveda Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEnveda Biosciences, Inc. receives financing of $55M in Series B2.Enveda Biosciences has secured $55m in a Series B2 financing round to expedite its platform and advance multiple candidates to clinical trials.

NewsEnveda Biosciences, Inc. partners with Microsoft.Enveda Biosciences collaborates with Microsoft to unveil PRISM: revolutionizing drug discovery with AI.

NewsEnveda Biosciences, Inc. received financing of $51M in Series A on Jun 22nd '21.Enveda Biosciences, a Boulder, CO-based drug discovery and development company, raised an additional $51m in Series B1 equity financing.